The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

APT Enters into Collaboration Agreement with Yale University to Manufacture and Supply Therapeutic Bacteriophage
Infectious Disease & AMR

APT Enters into Collaboration Agreement with Yale University to Manufacture and Supply Therapeutic Bacteriophage

JAN 2, 2019
Vedanta Biosciences Raises $27 Million Series C Financing to Advance Clinical Pipeline of Microbiome-Derived Product Candidates
Finance

Vedanta Biosciences Raises $27 Million Series C Financing to Advance Clinical Pipeline of Microbiome-Derived Product Candidates

DEC 24, 2018
EMA Rules On Omega-3 Medicinal Products – Useful Parallels for the Pharmabiotics Industry
Editor's Choice

EMA Rules On Omega-3 Medicinal Products – Useful Parallels for the Pharmabiotics Industry

DEC 21, 2018
BMS and Boston Medical Center Announce Research Collaboration to Investigate Markers of Immuno-Oncology Response and Resistance
Oncology

BMS and Boston Medical Center Announce Research Collaboration to Investigate Markers of Immuno-Oncology Response and Resistance

DEC 20, 2018
BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD
Gastrointestinal

BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD

DEC 14, 2018
DuPont Nutrition & Health Helps to Reduce Health Risks for Overweight Consumers
Biotics and Supplements

DuPont Nutrition & Health Helps to Reduce Health Risks for Overweight Consumers

DEC 13, 2018
BIOASTER, Bio-Rad and Genetic Analysis Collaborate to Develop Novel Microbiome-Based Diagnostics for Metabolic Disorders
Pharma & Human Health

BIOASTER, Bio-Rad and Genetic Analysis Collaborate to Develop Novel Microbiome-Based Diagnostics for Metabolic Disorders

DEC 12, 2018
BMS and Vedanta Announce Clinical Collaboration to Evaluate OPDIVO and VE800 in Patients with Advanced or Metastatic Cancers
Clinical & Manufacturing

BMS and Vedanta Announce Clinical Collaboration to Evaluate OPDIVO and VE800 in Patients with Advanced or Metastatic Cancers

DEC 10, 2018
Lallemand Health Solutions Invests to Double Probiotic Production Capacity.
Biotics and Supplements

Lallemand Health Solutions Invests to Double Probiotic Production Capacity.

DEC 10, 2018
Danone North America Announces 2018-2019 Gut Microbiome, Yogurt and Probiotics Fellowship Grant
Biotics and Supplements

Danone North America Announces 2018-2019 Gut Microbiome, Yogurt and Probiotics Fellowship Grant

DEC 9, 2018
MaaT Pharma Presents Positive Phase 1b/2a Study Results in Acute Myeloid Leukemia Patients
Clinical & Manufacturing

MaaT Pharma Presents Positive Phase 1b/2a Study Results in Acute Myeloid Leukemia Patients

DEC 3, 2018